Mouse Monoclonal Antibody to Nivolumab (Clone : 8G6G3D8), Clone: [8G6G3D8]
Biozol Catalog Number:
ABI-45-1086
Supplier Catalog Number:
45-1086
Alternative Catalog Number:
ABI-45-1086-40UG
Manufacturer:
Abeomics
Host:
Mouse
Category:
Antikörper
Application:
ELISA
Immunogen:
Nivolumab
Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Nivolumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Nivolumab.
Clonality:
Monoclonal
Clone Designation:
[8G6G3D8]
Purity:
Protein A chromatography
Form:
Purified
Application Dilute:
ELISA detection: 0.01-0.1 µg/ml
* VAT and and shipping costs not included. Errors and price changes excepted
